Regeneron Pharmaceuticals

Biotechnology

Regeneron is a biotechnology company known for its innovative approach to drug discovery using human genetics and proprietary technologies. The company developed blockbuster drugs including Eylea for eye diseases and Dupixent for inflammatory conditions. Regeneron's monoclonal antibody platform enabled rapid development of COVID-19 therapeutics.

The Biology of Business

Sign up to be notified when the book is available to order.

Notify Me